| |
Latest 10 SEC filings (by transaction date) for VCYT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -10,000 | $13.19 |
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Common Stock | S - Open market or private sale | -10,000 | $21.65 |
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 10,000 | $13.19 |
Mar 19/24 | Mar 15/24 | Chambers Rebecca | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,189 | $21.10 |
Mar 19/24 | Mar 15/24 | Chambers Rebecca | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,318 | |
Mar 19/24 | Mar 15/24 | Stapley Marc | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -5,971 | $21.10 |
Mar 19/24 | Mar 15/24 | Stapley Marc | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 11,780 | |
Mar 8/24 | Mar 6/24 | Stapley Marc | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 114,724 | |
Mar 8/24 | Mar 6/24 | Leite John | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 49,880 | |
Mar 8/24 | Mar 6/24 | McGuire Annie | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 49,880 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for VCYT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -10,000 | $13.19 |
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Common Stock | S - Open market or private sale | -10,000 | $21.65 |
Apr 2/24 | Apr 1/24 | Eastham Karin | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 10,000 | $13.19 |
Mar 19/24 | Mar 15/24 | Chambers Rebecca | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -2,189 | $21.10 |
Mar 19/24 | Mar 15/24 | Chambers Rebecca | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 4,318 | |
Mar 19/24 | Mar 15/24 | Stapley Marc | Direct Ownership | Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 | -5,971 | $21.10 |
Mar 19/24 | Mar 15/24 | Stapley Marc | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 11,780 | |
Mar 8/24 | Mar 6/24 | Stapley Marc | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 114,724 | |
Mar 8/24 | Mar 6/24 | Leite John | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 49,880 | |
Mar 8/24 | Mar 6/24 | McGuire Annie | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 49,880 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Iovance Biotherapeutics (OQ:IOVA) |
Exact Sciences (OQ:EXAS) |
Adaptive Biotechnologies (OQ:ADPT) |